Use your browser's back button to choose another title or click here for a New Search.

How to Get the Poster

 Open poster (pdf)




Bookmark and Share





Longitudinal Opioid Use in Patients Treatment with Buprenorphine: A "Missing Not At Random" (MNAR) and "Missing At Random" (MAR) Growth Model Comparison.

Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 9-14, 2012

Sterling McPherson, PhD (Washington State University, PN Node), Celestina Barbosa-Leiker, PhD (Washington State University, PN Node), Michael McDonell, PhD (University of Washington, PN Node), Donelle Howell, PhD (Washington State University, PN Node), John M. Roll, PhD (Washington State University, PN Node).

Because the analysis of a treatment's efficacy can vary as a function of how the missing data in a substance abuse clinical trial is handled analytically, there is a potential problem of not thoroughly evaluating and reporting the mechanism of missing information as part of the analytic strategy. Appropriate decision-making regarding how the missing data is handled is critical in order to make sound clinical inference based on randomized trials of substance abuse treatment, but missing not at random (MNAR) methodologies have no been explored in this context with real data. This investigation uses data from protocol CTN-0003 to compare 3 different modeling strategies for the handling of missing values (i.e., missing at random (MAR) model versus 2 different missing not at random (MNAR) models; Diggle-Kenward and Wu-Carroll selection modeling), to determine whether the treatment effect (i.e., impact of trial arm on linear urine analysis (UA) slope) is dependent on the missing data strategy used.

Conclusions: The trial arm effect on the UA slope (i.e., UA change over time), and other covariate effects, changed in a meaningful way across the MAR and MNAR growth models, indicating that missing data assumptions are critical to understand and explain in clinical trials. It is not only important for the research team to consider what the most likely missing data assumption is (i.e., MAR or MNAR), but also to consider whether or not the additional assumptions associated with each MNAR and MAR model are reasonable. This investigation highlights the potential for these modern approaches to missing data to shed new light on outcomes of interest (e.g., time-specific dropout) other than the primary outcome of UA. (Poster, PDF, English, 2012)

Keywords: CTN platform/ancillary study | Data management | Missing data | College on Problems of Drug Dependence (CPDD) annual meeting, 2012

Document No: 893

Submitted by Sterling McPherson, PhD, PN Node.


Barbosa-Leiker, Celestina
Howell, Donelle
McDonell, Michael
McPherson, Sterling search mail
Roll, John M. search
NIDA-CTN-0003 www

dark blue line
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 8/2012 --
dark blue line